FMR reports 8.1% stake in Ovintiv (OVV) on Schedule 13G/A
FMR LLC filed an amended Schedule 13G/A reporting beneficial ownership of 20,798,631.92 shares of Ovintiv Inc. common stock, or 8.1% of the class, as of 09/30/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FMR LLC filed an amended Schedule 13G/A reporting beneficial ownership of 20,798,631.92 shares of Ovintiv Inc. common stock, or 8.1% of the class, as of 09/30/2025. The filing also lists Abigail P. Johnson as a reporting person.
FMR reports sole voting power over 20,071,470.20 shares and sole dispositive power over 20,798,631.92 shares, with no shared voting or dispositive power. The certification states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
The filing notes that one or more other persons may have rights to dividends or sale proceeds tied to these shares, and no single other person’s interest exceeds five percent of the outstanding common stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did FMR LLC report about OVV in this Schedule 13G/A?
What voting and dispositive powers were disclosed for OVV?
Is Abigail P. Johnson included as a reporting person for OVV?
What is the date of the event that triggered this filing?
Does the filing indicate an attempt to influence control of Ovintiv?
Who signed the OVV Schedule 13G/A amendment?
AI-generated analysis. How Rhea-AI works. Not financial advice.